Long COVID and Serotonin: What’s Happening in Your Gut May Be Behind Your Brain Fog

Months after the fever broke and the cough cleared, something still isn’t right. The word-finding struggles. The mental fatigue that sleep doesn’t fix. The feeling of moving through life behind a pane of glass. For millions of people living with long COVID, this is the daily reality and for many, no one has been able to give them a biological explanation for why.

A 2023 study published in Cell out of Penn Medicine added some fascinating new data to the conversation, and unsurprisingly to those steeped in functional medicine, the gut is the star of the show.

What Most People Don’t Know About Serotonin

When most people hear “serotonin,” they think brain. Mood. Antidepressants. But here’s the thing — roughly 90 to 95% of your body’s serotonin is actually made in your gut, not your brain. It circulates in the bloodstream, stored in platelets, and plays a key role in regulating the vagus nerve, which is the main communication line between your gut and brain. Functional psychiatry clinicians have long understood how central this gut-brain axis is to mental health. What the new research suggests is that in long COVID, this system may be malfunctioning.

Here’s how the chain seems to unfold. In some patients, remnants of the SARS-CoV-2 virus linger in the GI tract long after the acute infection has resolved. That lingering viral presence keeps the immune system activated, triggering the ongoing release of interferons, proteins the body uses to fight viruses. Those interferons interfere with the gut’s ability to absorb tryptophan, the amino acid the body needs to produce serotonin. On top of that, platelet dysfunction further depletes serotonin stores, and certain enzymes that break serotonin down appear to become overactive. Through multiple mechanisms, the result is a meaningful drop in serotonin levels.

Less peripheral serotonin means a quieter vagus nerve. A quieter vagus nerve means reduced activity in the hippocampus, the brain region central to memory and learning. And that may be a significant piece of why so many long COVID patients describe a brain fog that won’t lift.

What the Long Covid Research Shows — and Where to Be Careful

The Penn study was thorough, gathering metabolomic data from human patients, mouse models, and intestinal organoid cultures to build its case. Perhaps the most striking finding was in the animal models, where memory impairment was actually reversed using tryptophan supplementation or fluoxetine (Prozac). That’s a genuinely exciting proof of concept.

But there’s more work to be done in terms of fleshing out the mechanism. A subsequent commentary published in the Journal of Inflammation Research raised a real methodological concern — the way blood samples were processed in the study may not have accurately captured platelet-bound serotonin, which is a key part of the argument. That question hasn’t been resolved. More importantly, no human clinical trial has yet tested whether replenishing serotonin actually improves long COVID symptoms. And SSRI studies in COVID patients more broadly have shown mixed results. This is a biologically compelling hypothesis, not yet a treatment protocol.

What This Actually Means for Treating the Symptoms of Long Covid

This research matters for both patients and providers, and here’s the practical takeaway.

For long COVID patients struggling with brain fog, memory issues, or mood changes, especially if GI symptoms are present, this pathway may be relevant to what they’re experiencing. Those gut symptoms may not be a separate problem, but instead part of the same story.

Targeting the gut-serotonin connection may be a logical place to start. That could look like addressing underlying GI dysfunction, optimizing tryptophan intake through diet, or considering targeted supplementation like L-Tryptophan or 5-HTP, particularly when mood, sleep, and cognitive symptoms are all present. The human data specific to long COVID is still emerging, but the biological rationale is solid and these approaches are generally well-tolerated.

For clinicians, this is a framework worth bringing into patient conversations. Long COVID patients are frequently told their symptoms are anxiety, deconditioning, or just stress. Being able to explain a plausible biological pathway, one rooted in gut health, immune function, and the gut-brain axis, is often validating when someone has spent months feeling dismissed and misunderstood.

The Bottom Line

Long COVID is almost certainly not a single disease. It’s more likely several overlapping dynamics that share a name. The gut-serotonin-vagus pathway is one of the more coherent biological explanations we have for the cognitive and autonomic symptoms that define so many patients’ experiences and it fits naturally within a functional psychiatry framework. Admittedly, the research is early and the clinical applications are still taking shape. But for patients who are suffering and searching for answers, it may serve as a useful starting point when considering treatment approaches.